These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18065096)

  • 1. New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.
    Pasquinucci L; Iadanza M; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Parenti C; De Luca L; Ronsisvalle G
    Pharmazie; 2007 Nov; 62(11):813-24. PubMed ID: 18065096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of N-substitution in 6,7-benzomorphan compounds.
    Pasquinucci L; Prezzavento O; Marrazzo A; Amata E; Ronsisvalle S; Georgoussi Z; Fourla DD; Scoto GM; Parenti C; Aricò G; Ronsisvalle G
    Bioorg Med Chem; 2010 Jul; 18(14):4975-82. PubMed ID: 20599386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of (+)-MR200 as a new selective sigma ligand modulating MOP, DOP and KOP supraspinal analgesia.
    Marrazzo A; Parenti C; Scavo V; Ronsisvalle S; Scoto GM; Ronsisvalle G
    Life Sci; 2006 Apr; 78(21):2449-53. PubMed ID: 16324720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
    Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methyl] benzomorphan.
    Zhou Q; Duan WH; Cohen DJ; Bidlack JM; Wentland MP
    Yao Xue Xue Bao; 2003 Oct; 38(10):748-53. PubMed ID: 14730897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of (+)-(1'R,2'S) and (1'S,2'R)-6,11-dimethyl-1,2,3,4,5,6 -hexahydro-3-[[2'-(alkoxycarbonyl)-2'-phenylcyclopropyl]methyl]-2 ,6 -methano-3-benzazocin-8-ol. Comparison of the affinities for sigma 1 and opioid receptors with in the diastereoisomeric MPCB and CCB.
    Ronsisvalle G; Prezzavento O; Pasquinucci L; Pappalardo MS; Marrazzo A; Vittorio F; Carboni L; Spampinato S
    Farmaco; 1997; 52(6-7):471-6. PubMed ID: 9372600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors.
    Zhang A; Xiong W; Bidlack JM; Hilbert JE; Knapp BI; Wentland MP; Neumeyer JL
    J Med Chem; 2004 Jan; 47(1):165-74. PubMed ID: 14695830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.
    Cappelli A; Anzini M; Vomero S; Menziani MC; De Benedetti PG; Sbacchi M; Clarke GD; Mennuni L
    J Med Chem; 1996 Feb; 39(4):860-72. PubMed ID: 8632410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (4-Carboxamido)phenylalanine is a surrogate for tyrosine in opioid receptor peptide ligands.
    Dolle RE; Machaut M; Martinez-Teipel B; Belanger S; Cassel JA; Stabley GJ; Graczyk TM; DeHaven RN
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3545-8. PubMed ID: 15177470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.
    Li F; Yin C; Chen J; Liu J; Xie X; Zhang A
    Chem Biol Drug Des; 2009 Oct; 74(4):335-42. PubMed ID: 19691470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.
    Wentland MP; VanAlstine M; Kucejko R; Lou R; Cohen DJ; Parkhill AL; Bidlack JM
    J Med Chem; 2006 Sep; 49(18):5635-9. PubMed ID: 16942039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
    Dardonville C; Fernandez-Fernandez C; Gibbons SL; Ryan GJ; Jagerovic N; Gabilondo AM; Meana JJ; Callado LF
    Bioorg Med Chem; 2006 Oct; 14(19):6570-80. PubMed ID: 16797997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex.
    Grauert M; Bechtel WD; Ensinger HA; Merz H; Carter AJ
    J Med Chem; 1997 Aug; 40(18):2922-30. PubMed ID: 9288174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
    Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
    J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of dynorphin a analogues modified in the address sequence.
    Schlechtingen G; DeHaven RN; Daubert JD; Cassel JA; Chung NN; Schiller PW; Taulane JP; Goodman M
    J Med Chem; 2003 May; 46(11):2104-9. PubMed ID: 12747782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of 4-(N,N-diarylamino)piperidines with high selectivity to the delta-opioid receptor: a combined 3D-QSAR and ligand docking study.
    Podlogar BL; Poda GI; Demeter DA; Zhang SP; Carson JR; Neilson LA; Reitz AB; Ferguson DM
    Drug Des Discov; 2000; 17(1):34-50. PubMed ID: 10928448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of residues 3 and 4 in cyclic tetrapeptide ligand recognition by the kappa-opioid receptor.
    Przydzial MJ; Pogozheva ID; Bosse KE; Andrews SM; Tharp TA; Traynor JR; Mosberg HI
    J Pept Res; 2005 Mar; 65(3):333-42. PubMed ID: 15787963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence.
    Neumeyer JL; Bidlack JM; Zong R; Bakthavachalam V; Gao P; Cohen DJ; Negus SS; Mello NK
    J Med Chem; 2000 Jan; 43(1):114-22. PubMed ID: 10633042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of intra-nucleus accumbens mu and kappa opioid agonists on sensory specific satiety.
    Woolley JD; Lee BS; Kim B; Fields HL
    Neuroscience; 2007 Jun; 146(4):1445-52. PubMed ID: 17445988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.